Identification of MiPEP133 As a Novel Tumor-suppressor Microprotein Encoded by MiR-34a Pri-miRNA

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2020 Sep 15

PMID 32928232

Citations 44

Authors

Min Kang

Bo Tang

Jixi Li

Ziyan Zhou

Kang Liu

RenSheng Wang

Ziyan Jiang

Fangfang Bi

David Patrick

Dongin Kim

Anirban K Mitra

Yang Yang-Hartwich

Affiliations

Soon will be listed here.

Abstract

Background: Very few proteins encoded by the presumed non-coding RNA transcripts have been identified. Their cellular functions remain largely unknown. This study identifies the tumor-suppressor function of a novel microprotein encoded by the precursor of miR-34a. It consists of 133 amino acid residues, thereby named as miPEP133 (pri-microRNA encoded peptide 133).

Methods: We overexpressed miPEP133 in nasopharyngeal carcinoma (NPC), ovarian cancer and cervical cancer cell lines to determine its effects on cell growth, apoptosis, migration, or invasion. Its impact on tumor growth was evaluated in a xenograft NPC model. Its prognostic value was analyzed using NPC clinical samples. We also conducted western blot, immunoprecipitation, mass spectrometry, confocal microscopy and flow cytometry to determine the underlying mechanisms of miPEP133 function and regulation.

Results: miPEP133 was expressed in normal human colon, stomach, ovary, uterus and pharynx. It was downregulated in cancer cell lines and tumors. miPEP133 overexpression induced apoptosis in cancer cells and inhibited their migration and invasion. miPEP133 inhibited tumor growth in vivo. Low miPEP133 expression was an unfavorable prognostic marker associated with advanced metastatic NPC. Wild-type p53 but not mutant p53 induced miPEP133 expression. miPEP133 enhanced p53 transcriptional activation and miR-34a expression. miPEP133 localized in the mitochondria to interact with mitochondrial heat shock protein 70kD (HSPA9) and prevent HSPA9 from interacting with its binding partners, leading to the decrease of mitochondrial membrane potential and mitochondrial mass.

Conclusion: miPEP133 is a tumor suppressor localized in the mitochondria. It is a potential prognostic marker and therapeutic target for multiple types of cancers.

Citing Articles

Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential.

Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X J Hematol Oncol. 2025; 18(1):20.

PMID: 39972384 PMC: 11841355. DOI: 10.1186/s13045-025-01671-9.

Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation.

Vrbnjak K, Sewduth R Pharmaceutics. 2024; 16(11).

PMID: 39598608 PMC: 11597556. DOI: 10.3390/pharmaceutics16111486.

Emerging role of endogenous peptides encoded by non-coding RNAs in cancer biology.

Tornesello A, Cerasuolo A, Starita N, Amiranda S, Cimmino T, Bonelli P Noncoding RNA Res. 2024; 10:231-241.

PMID: 39554691 PMC: 11567935. DOI: 10.1016/j.ncrna.2024.10.006.

Non-canonical translation in cancer: significance and therapeutic potential of non-canonical ORFs, mA-modification, and circular RNAs.

Deng X, Yu Y, Jin Y Cell Death Discov. 2024; 10(1):412.

PMID: 39333489 PMC: 11437038. DOI: 10.1038/s41420-024-02185-y.

Multi-Omic Approaches in Cancer-Related Micropeptide Identification.

Vrbnjak K, Sewduth R Proteomes. 2024; 12(3).

PMID: 39311199 PMC: 11417835. DOI: 10.3390/proteomes12030026.

References

Harner M, Neupert W, Deponte M . Lateral release of proteins from the TOM complex into the outer membrane of mitochondria. EMBO J. 2011; 30(16):3232-41. PMC: 3160657. DOI: 10.1038/emboj.2011.235. View

Lee A, Sze W, Au J, Leung S, Leung T, Chua D . Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005; 61(4):1107-16. DOI: 10.1016/j.ijrobp.2004.07.702. View

Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N . Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26(5):731-43. DOI: 10.1016/j.molcel.2007.05.017. View

Chou J, Lin Y, Kim J, You L, Xu Z, He B . Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck. 2008; 30(7):946-63. PMC: 3046044. DOI: 10.1002/hed.20833. View

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View

Chatterjee K, Das P, Roy Chattopadhyay N, Mal S, Choudhuri T . The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies. Heliyon. 2019; 5(11):e02624. PMC: 6893087. DOI: 10.1016/j.heliyon.2019.e02624. View

Bottinger L, Oeljeklaus S, Guiard B, Rospert S, Warscheid B, Becker T . Mitochondrial heat shock protein (Hsp) 70 and Hsp10 cooperate in the formation of Hsp60 complexes. J Biol Chem. 2015; 290(18):11611-22. PMC: 4416864. DOI: 10.1074/jbc.M115.642017. View

Wadhwa R, Taira K, Kaul S . An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where?. Cell Stress Chaperones. 2002; 7(3):309-16. PMC: 514830. DOI: 10.1379/1466-1268(2002)007<0309:ahfcmm>2.0.co;2. View

Schneider H, Berthold J, Bauer M, Dietmeier K, Guiard B, Brunner M . Mitochondrial Hsp70/MIM44 complex facilitates protein import. Nature. 1994; 371(6500):768-74. DOI: 10.1038/371768a0. View

10.

Park S, Shin J, Jeong J, Song J, Jo Y, Kim E . Down-regulation of mortalin exacerbates Aβ-mediated mitochondrial fragmentation and dysfunction. J Biol Chem. 2013; 289(4):2195-204. PMC: 3900965. DOI: 10.1074/jbc.M113.492587. View

11.

Kaula S, Reddelb R, Sugiharac T, Mitsuia Y, Wadhwac R . Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2. FEBS Lett. 2000; 474(2-3):159-64. DOI: 10.1016/s0014-5793(00)01594-5. View

12.

Anderson D, Anderson K, Chang C, Makarewich C, Nelson B, McAnally J . A micropeptide encoded by a putative long noncoding RNA regulates muscle performance. Cell. 2015; 160(4):595-606. PMC: 4356254. DOI: 10.1016/j.cell.2015.01.009. View

13.

Wadhwa R, Takano S, Kaur K, Aida S, Yaguchi T, Kaul Z . Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60. Biochem J. 2005; 391(Pt 2):185-90. PMC: 1276915. DOI: 10.1042/BJ20050861. View

14.

Schwarzer C, Thinnes F, Hilschmann N . Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctex1 and the heat-shock protein PBP74. Int J Biochem Cell Biol. 2002; 34(9):1059-70. DOI: 10.1016/s1357-2725(02)00026-2. View

15.

Tiscornia G, Singer O, Verma I . Production and purification of lentiviral vectors. Nat Protoc. 2007; 1(1):241-5. DOI: 10.1038/nprot.2006.37. View

16.

Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y . Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2014; 27(3):443-52. DOI: 10.1016/j.cellsig.2014.12.003. View

17.

Mullany L, Wong K, Marciano D, Katsonis P, King-Crane E, Ren Y . Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival. Neoplasia. 2015; 17(10):789-803. PMC: 4656807. DOI: 10.1016/j.neo.2015.10.003. View

18.

McCormick T, Canedo N, Furtado Y, Silveira F, de Lima R, Rosman A . Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study. Diagn Pathol. 2015; 10:59. PMC: 4450846. DOI: 10.1186/s13000-015-0283-3. View

19.

Su X, Chakravarti D, Cho M, Liu L, Gi Y, Lin Y . TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. Nature. 2010; 467(7318):986-90. PMC: 3055799. DOI: 10.1038/nature09459. View

20.

Chang T, Wentzel E, Kent O, Ramachandran K, Mullendore M, Lee K . Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007; 26(5):745-52. PMC: 1939978. DOI: 10.1016/j.molcel.2007.05.010. View